Beating a dead horse, back in at $2.33Again, not a $2.70 stock yet, so if it goes back up to $2.70 I will sell absent substantial news. Nothing outside of a quality asset purchase or forward revenue guidance justifies a $2.70 stock price, but that hasn't stopped CloudMD from repeatedly hitting that price target (and subsequently tumbling down a week or two later).
10% a week is great though.